Pyxis Oncology Company
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Industry:
Gene therapy
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2019-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
21
Total Funding:
174000000
Last Funding Date:
2021
Last Funding Type:
Series B
Register and Claim Ownership